| 包装: | 1mg |
| 规格: | 98% |
| 市场价: | 283元 |
| 分子量: | 260.3 |
Background:
Carisoprodol (CRM) is a certified reference material categorized as a skeletal muscle relaxant.1 It also has sedative properties.2 Carisoprodol is regulated as a Schedule IV compound in the United States. Carisoprodol (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
参考文献
1. Reeves, R.R., Burke, R.S., and Kose, S. Carisoprodol: Update on abuse potential and legal status. South Med.J. 105, 619-623 (2012).
2. Gonzalez, L.A., Gatch, M.B., Taylor, C.M., et al. Carisoprodol-mediated modulation of GABAA receptors: In vitro and in vivo studies. J. Pharmacol. Exp. Ther. 329(2), 827-837 (2009).
m.cnreagent.com